• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为心功能无创替代指标的波强度测量可预测血液透析患者的死亡率。

Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients.

作者信息

Mayer Christopher C, Sarafidis Pantelis A, Matschkal Julia, Theodorakopoulou Marieta, Lorenz Georg, Karagiannidis Artemios, Angermann Susanne, Iatridi Fotini, Braunisch Matthias C, Karpetas Antonios, Baumann Marcus, Pella Eva, Heemann Uwe, Wassertheurer Siegfried, Schmaderer Christoph

机构信息

AIT Austrian Institute of Technology, Center for Health & Bioresources, Medical Signal Analysis, Vienna, Austria.

TU Wien, Institute for Analysis and Scientific Computing, Vienna, Austria.

出版信息

Clin Kidney J. 2024 Jun 27;17(7):sfae172. doi: 10.1093/ckj/sfae172. eCollection 2024 Jul.

DOI:10.1093/ckj/sfae172
PMID:39056069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270016/
Abstract

BACKGROUND

Risk prediction in haemodialysis (HD) patients is challenging due to the impact of the dialysis regime on the patient's volume status and the complex interplay with cardiac function, comorbidities and hypertension. Cardiac function as a key predictor of cardiovascular (CV) mortality in HD patients is challenging to assess in daily routine. Thus the aim of this study was to investigate the association of a novel, non-invasive relative index of systolic function with mortality and to assess its interplay with volume removal.

METHODS

A total of 558 (373 male/185 female) HD patients with a median age of 66 years were included in this analysis. They underwent 24-hour ambulatory blood pressure monitoring, including wave intensity analysis [i.e. S:D ratio (SDR)]. All-cause and CV mortality served as endpoints and multivariate proportional hazards models were used for risk prediction. Intradialytic changes were analysed in tertiles according to ultrafiltration volume. During a follow-up of 37.8 months, 193 patients died (92 due to CV reasons).

RESULTS

The SDR was significantly associated with all-cause {univariate hazard ratio [HR] 1.36 [95% confidence interval (CI) 1.20-1.54],  < .001} and CV [univariate HR 1.41 (95% CI 1.20-1.67),  < .001] mortality. The associations remained significant in multivariate analysis accounting for possible confounders. Changes in the SDR from pre-/early- to post-dialytic averages were significantly different for the three ultrafiltration volume groups.

CONCLUSION

This study provides well-powered evidence for the independent association of a novel index of systolic function with mortality. Furthermore, it revealed a significant association between intradialytic changes of the measure and intradialytic volume removal.

摘要

背景

由于透析方案对患者容量状态的影响以及与心功能、合并症和高血压之间复杂的相互作用,血液透析(HD)患者的风险预测具有挑战性。心功能作为HD患者心血管(CV)死亡率的关键预测指标,在日常临床中评估具有挑战性。因此,本研究的目的是探讨一种新的、非侵入性的收缩功能相对指标与死亡率的关联,并评估其与容量清除的相互作用。

方法

本分析纳入了558例(373例男性/185例女性)HD患者,中位年龄为66岁。他们接受了24小时动态血压监测,包括波强度分析[即S:D比值(SDR)]。全因死亡率和CV死亡率作为终点,采用多变量比例风险模型进行风险预测。根据超滤量将透析期间的变化分为三分位数进行分析。在37.8个月的随访期间,193例患者死亡(92例死于CV原因)。

结果

SDR与全因死亡率{单变量风险比[HR]1.36[95%置信区间(CI)1.20 - 1.54],P <.001}和CV死亡率[单变量HR 1.41(95%CI 1.20 - 1.67),P <.001]显著相关。在考虑了可能的混杂因素的多变量分析中,这种关联仍然显著。三个超滤量组从透析前/早期到透析后平均SDR的变化有显著差异。

结论

本研究为一种新的收缩功能指标与死亡率的独立关联提供了有力证据。此外,它还揭示了该指标在透析期间的变化与透析期间容量清除之间的显著关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/b770643cdda7/sfae172fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/02f44b0b0f46/sfae172fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/c85d7b37aa8f/sfae172fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/e23275e070b8/sfae172fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/b770643cdda7/sfae172fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/02f44b0b0f46/sfae172fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/c85d7b37aa8f/sfae172fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/e23275e070b8/sfae172fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9bf/11270016/b770643cdda7/sfae172fig3.jpg

相似文献

1
Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients.作为心功能无创替代指标的波强度测量可预测血液透析患者的死亡率。
Clin Kidney J. 2024 Jun 27;17(7):sfae172. doi: 10.1093/ckj/sfae172. eCollection 2024 Jul.
2
All-cause mortality in relation to changes in relative blood volume during hemodialysis.全因死亡率与血液透析过程中相对血容量变化的关系。
Nephrol Dial Transplant. 2019 Aug 1;34(8):1401-1408. doi: 10.1093/ndt/gfy286.
3
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.透析间期血压变异性与血液透析患者心血管事件及全因死亡率的关系。
Nephrol Dial Transplant. 2019 Mar 1;34(3):515-523. doi: 10.1093/ndt/gfy247.
4
An analysis of the impact of fluid overload and fluid depletion for all-cause and cardiovascular mortality.分析液体超负荷和液体缺失对全因和心血管死亡率的影响。
Nephrol Dial Transplant. 2019 Aug 1;34(8):1385-1393. doi: 10.1093/ndt/gfy396.
5
Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus.可溶性肿瘤发生抑制因子-2是糖尿病血液透析患者全因、心血管及感染相关死亡风险的有力预测指标。
Clin Kidney J. 2022 May 18;15(10):1915-1923. doi: 10.1093/ckj/sfac142. eCollection 2022 Oct.
6
Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.脑利钠肽在血液透析患者传统和非传统危险因素之间的作用:对两年随访中心血管死亡率的分析。
Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.
7
Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes?血液透析急性恶化左、右心室舒张功能和心肌收缩功能:与超滤量高有关的影响?
Nephrol Dial Transplant. 2017 Aug 1;32(8):1402-1409. doi: 10.1093/ndt/gfw345.
8
Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis.血液透析期间生物电阻抗参数与血压升高的关联
Clin J Am Soc Nephrol. 2024 Mar 1;19(3):329-335. doi: 10.2215/CJN.0000000000000356. Epub 2023 Nov 16.
9
Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.诊室血压和动态血压与死亡率及心血管结局的关联。
JAMA. 2019 Aug 6;322(5):409-420. doi: 10.1001/jama.2019.9811.
10
Intradialytic hypertension is a marker of volume excess.透析中高血压是容量过多的一个标志。
Nephrol Dial Transplant. 2010 Oct;25(10):3355-61. doi: 10.1093/ndt/gfq210. Epub 2010 Apr 16.

本文引用的文献

1
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk.SPARTE 研究:中至高心血管风险的高血压患者的动脉僵硬度正常化和心血管事件。
Hypertension. 2021 Sep;78(4):983-995. doi: 10.1161/HYPERTENSIONAHA.121.17579. Epub 2021 Aug 30.
2
Measurement, Analysis and Interpretation of Pressure/Flow Waves in Blood Vessels.血管中压力/血流波的测量、分析与解读
Front Physiol. 2020 Aug 27;11:1085. doi: 10.3389/fphys.2020.01085. eCollection 2020.
3
Heart Failure and Atrial Fibrillation Modify the Associations of Nocturnal Blood Pressure Dipping Pattern With Mortality in Hemodialysis Patients.
心力衰竭和心房颤动改变了血液透析患者夜间血压下降模式与死亡率的关联。
Hypertension. 2020 Oct;76(4):1231-1239. doi: 10.1161/HYPERTENSIONAHA.120.15420. Epub 2020 Aug 31.
4
Feasibility of Estimation of Aortic Wave Intensity Using Non-invasive Pressure Recordings in the Absence of Flow Velocity in Man.在人体缺乏血流速度的情况下使用无创压力记录评估主动脉波强度的可行性。
Front Physiol. 2020 May 25;11:550. doi: 10.3389/fphys.2020.00550. eCollection 2020.
5
Carotid artery wave intensity in mid- to late-life predicts cognitive decline: the Whitehall II study.中老年颈动脉波强预测认知能力下降:白厅 II 研究。
Eur Heart J. 2019 Jul 21;40(28):2300-2309. doi: 10.1093/eurheartj/ehz189.
6
Comparison of 24-hour and Office Pulse Wave Velocity for Prediction of Mortality in Hemodialysis Patients.24 小时与诊室脉搏波速度比较预测血液透析患者死亡率。
Am J Nephrol. 2019;49(4):317-327. doi: 10.1159/000499532. Epub 2019 Mar 27.
7
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.透析间期血压变异性与血液透析患者心血管事件及全因死亡率的关系。
Nephrol Dial Transplant. 2019 Mar 1;34(3):515-523. doi: 10.1093/ndt/gfy247.
8
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.通过48小时动态血压监测评估血液透析患者高血压的患病率及控制情况:欧洲肾脏协会-欧洲透析和移植协会(ERA-EDTA)的欧洲心血管和肾脏医学(EURECA-m)工作组的一项研究
Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy263.
9
Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation.血液透析患者动态血压与全因及心血管死亡率的相关性:心力衰竭和心房颤动的影响。
J Am Soc Nephrol. 2018 Sep;29(9):2409-2417. doi: 10.1681/ASN.2018010086. Epub 2018 Jul 25.
10
The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.终末期肾病患者血液透析治疗中心脏超声心动图心功能参数的变化。
J Am Soc Nephrol. 2018 May;29(5):1372-1381. doi: 10.1681/ASN.2017101102. Epub 2018 Mar 28.